CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Key market players
1.5.Research methodology

1.5.1.Primary research
1.5.2.Secondary research
1.5.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Market player positioning, 2019
3.4.Porter's five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in aging population
3.5.1.2.Increase in acceptance toward adult incontinence
3.5.1.3.Growth in e-commerce
3.5.1.4.Efficiency in the prevention of hospital-acquired infections (HAIs)

3.5.2.Restraints

3.5.2.1.Embarrassment in using adult incontinence products
3.5.2.2.Rise in concern toward disposal of products

3.5.3.Opportunity

3.5.3.1.Technological integration

3.6.COVID-19 Impact analysis

CHAPTER 4:NORTH AMERICA ADULT INCONTINENCE PRODUCTS MARKET, BY PRODUCT TYPE

4.1.Market overview

4.1.1.Market size and forecast, by product type

4.2.Diapers

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast

4.3.Panty Shields

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast

4.4.Underwear

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast

4.5.Under Pads

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast

CHAPTER 5:NORTH AMERICA ADULT INCONTINENCE PRODUCTS MARKET, BY INCONTINENCE TYPE

5.1.Market overview

5.1.1.Market size and forecast, by incontinence type

5.2.Stress urinary incontinence

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast

5.3.Urge Urinary Incontinence

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast

5.4.Overflow incontinence

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast

5.5.Functional urinary incontinence

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast

CHAPTER 6:NORTH AMERICA ADULT INCONTINENCE PRODUCTS MARKET, BY DISTRIBUTION CHANNEL

6.1.Market overview

6.1.1.Market size and forecast, by distribution channel

6.2.Online

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast

6.3.Offline

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast

CHAPTER 7:NORTH AMERICA ADULT INCONTINENCE PRODUCTS MARKET, BY USAGE

7.1.Market overview

7.1.1.Market size and forecast, by usage

7.2.Disposable

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast

7.3.Reusable

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast

CHAPTER 8:NORTH AMERICA ADULT INCONTINENCE PRODUCTS MARKET, BY COUNTRY

8.1.Overview

8.1.1.U.S.

8.1.1.1.U.S. market size and forecast, by product type
8.1.1.2.U.S. market size and forecast, by incontinence type
8.1.1.3.U.S. market size and forecast, by distribution channel
8.1.1.4.U.S. market size and forecast, by usage

8.1.2.Canada

8.1.2.1.Canada market size and forecast, by product type
8.1.2.2.Canada market size and forecast, by incontinence type
8.1.2.3.Canada market size and forecast, by distribution channel
8.1.2.4.Canada market size and forecast, by usage

8.1.3.Mexico

8.1.3.1.Mexico market size and forecast, by product type
8.1.3.2.Mexico market size and forecast, by incontinence type
8.1.3.3.Mexico market size and forecast, by distribution channel
8.1.3.4.Mexico market size and forecast, by usage

CHAPTER 9:COMPANY PROFILES

9.1.CARDINAL HEALTH, INC.

9.1.1.Company overview
9.1.2.Key executive
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.Business performance
9.1.7.Key strategic moves and developments

9.2.DRYLOCK TECHNOLOGIES NV

9.2.1.Company overview
9.2.2.Key executive
9.2.3.Company snapshot
9.2.4.Product portfolio
9.2.5.Key strategic moves and developments

9.3.DOMTAR CORPORATION

9.3.1.Company overview
9.3.2.Key executive
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Business performance
9.3.7.Key strategic moves and developments

9.4.ESSITY AKTIEBOLAG (PUBL).

9.4.1.Company overview
9.4.2.Key executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.Research and development expenses
9.4.7.Business performance
9.4.8.Key strategic moves and developments

9.5.FIRST QUALITY ENTERPRISES, INC.

9.5.1.Company overview
9.5.2.Key executive
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio

9.6.HEALTH CARE PRODUCTS, INC.

9.6.1.Company overview
9.6.2.Key executive
9.6.3.Company snapshot
9.6.4.Product portfolio

9.7.KIMBERLY-CLARK CORPORATION

9.7.1.Company overview
9.7.2.Key executive
9.7.3.Company snapshot
9.7.4.Operating business segment
9.7.5.Product portfolio
9.7.6.Research and development expenses
9.7.7.Business performance
9.7.8.Key strategic moves and developments

9.8.ONTEX GROUP NV

9.8.1.Company overview
9.8.2.Key executive
9.8.3.Company snapshot
9.8.4.Operating business segments
9.8.5.Product portfolio
9.8.6.R&D expenditure
9.8.7.Business performance
9.8.8.Key strategic moves and developments

9.9.PROCTER & GAMBLE

9.9.1.Company overview
9.9.2.Key executive
9.9.3.Company snapshot
9.9.4.Operating business segments
9.9.5.Product portfolio
9.9.6.R&D expenditure
9.9.7.Business performance

9.10.PRINCIPLE BUSINESS ENTERPRISES, INC.

9.10.1.Company overview
9.10.2.Key executive
9.10.3.Company snapshot
9.10.4.Product portfolio